143 related articles for article (PubMed ID: 7369275)
1. Elevated titers of the beta subunit of human chorionic gonadotropin in oophorectomized women being treated for trophoblastic disease.
Hatch KD; Shingleton HM; Younger B; Boots LR
Am J Obstet Gynecol; 1980 May; 137(1):122-6. PubMed ID: 7369275
[TBL] [Abstract][Full Text] [Related]
2. The management of patients with gestational trophoblastic neoplasia based on the antigenic properties of human chorionic gonadotropin.
Goldstein DP; Nudemberg F; Lymeburner N; Levesque L; Shore C
J Surg Oncol; 1973; 5(1):1-8. PubMed ID: 4736212
[No Abstract] [Full Text] [Related]
3. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
Braga A; Torres B; Burlá M; Maestá I; Sun SY; Lin L; Madi JM; Uberti E; Viggiano M; Elias KM; Berkowitz RS
Gynecol Oncol; 2016 Dec; 143(3):558-564. PubMed ID: 27640962
[TBL] [Abstract][Full Text] [Related]
4. Malignant trophoblastic neoplasia. Monitoring of therapy.
Kolstad P; Hoeg K; Norman N
Acta Obstet Gynecol Scand; 1972; 51(3):275-81. PubMed ID: 4342019
[No Abstract] [Full Text] [Related]
5. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
7. Evidence suggesting the trophoblastic origin of follicle-stimulating hormone, luteinizing hormone and prolactin in hydatidiform mole.
Loganath A; Peh KL; Gunasegaram R; Ratnam SS
Asia Oceania J Obstet Gynaecol; 1988 Sep; 14(3):383-8. PubMed ID: 2460076
[No Abstract] [Full Text] [Related]
8. Monitor of chemotherapy in gestational trophoblastic neoplasm by radioimmunoassay of the beta-subunit of human chorionic gonadotropin.
Jones WB; Lewis JL; Lehr M
Am J Obstet Gynecol; 1975 Mar; 121(5):669-73. PubMed ID: 46716
[TBL] [Abstract][Full Text] [Related]
9. Clinical comparison of immunoradiometric assays for intact versus beta-specific human chorionic gonadotropin.
Pardue MG; Taylor EH; London S; Walls RC; Pappas AA
Am J Clin Pathol; 1990 Mar; 93(3):347-51. PubMed ID: 1689940
[TBL] [Abstract][Full Text] [Related]
10. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
Rotmensch J; Rosenshein NB; Block BS
Gynecol Oncol; 1988 Jan; 29(1):82-6. PubMed ID: 2448190
[TBL] [Abstract][Full Text] [Related]
11. Criteria of complete remission from trophoblastic neoplasia with the use of human chorionic gonadotropin (HCG) excretion pattern as a parameter.
Tomoda Y; Asai Y; Arii Y; Kaseki S; Nishi H; Miwa T; Saiki N; Ishizuka N
Cancer; 1977 Sep; 40(3):1016-25. PubMed ID: 198083
[TBL] [Abstract][Full Text] [Related]
12. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
Jones WB; Lehr M; Lewis JL
Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
[No Abstract] [Full Text] [Related]
14. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
[TBL] [Abstract][Full Text] [Related]
15. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
Yuen BH; Cannon W; Benedet JL; Boyes DA
Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
[TBL] [Abstract][Full Text] [Related]
16. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
[TBL] [Abstract][Full Text] [Related]
17. The human chorionic gonadotropin molecule from patients with trophoblastic diseases has a high thyrotropic activity but is less active in the ovary.
Kato K; Mostafa MH; Mann K; Schindler AE; Hoermann R
Gynecol Endocrinol; 2004 May; 18(5):269-77. PubMed ID: 15346663
[TBL] [Abstract][Full Text] [Related]
18. Postmolar trophoblastic disease in women using hormonal contraception with and without estrogen.
Eddy GL; Schlaerth JB; Nalick RH; Gaddis O; Nakamura RM; Morrow CP
Obstet Gynecol; 1983 Dec; 62(6):736-40. PubMed ID: 6633999
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
20. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
